Developer docs
API playgroundTry for free, no card

Search company profiles

Green Bioactives

Full company profile

uuid00036nk

Namestring
Green Bioactives
Legal namestring
Green Bioactives Ltd
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Green Bioactives Ltd is a Scottish plant cell-based biomanufacturing company that develops and produces high-value bioactive molecules for the cosmetics, pharmaceutical, food, and agriculture sectors. The company's core technology is a proprietary plant cell culture platform that utilizes plant vascular stem cells and natural plant biochemistry to produce target biomolecules sustainably, independent of seasonality, climate, or agricultural supply chains. The platform combines enabling technologies, expertise, and intellectual property to control the complete production process and increase yields of target molecules, with demonstrated applications including paclitaxel production for chemotherapy and sustainable cosmetic ingredient manufacturing.

The company originated from research at the University of Edinburgh and was established through the ICURe programme funded by Innovate UK in 2018-2019. It operates from a research lab at the Roslin Innovation Centre and headquarters at Pentlands Science Park in Penicuik, Scotland. The team is led by founder/CSO Gary Loake (former Edinburgh professor) and CEO David McElroy (experienced agbio entrepreneur), with senior leadership including CBO Chris Meaney, CFO John Craig, and Head of Operations Andy Hall-Ponselé.

Green Bioactives generates revenue through direct B2B sales of sustainably manufactured bioactive ingredients to enterprise customers in target industries, using a quote-based pricing model for bulk ingredient orders. The company pursues a horizontal go-to-market strategy across four verticals and relies on partnership-driven market access and its university spin-out heritage for credibility. To date, the company has raised a £2.6M seed round led by Eos Advisory LLP (December 2022) and secured up to £1.1M in grant funding from Scottish Enterprise (April 2025) to scale its technology for the cosmetics and personal care market.

Short descriptiontext

Green Bioactives is a Scottish plant cell-based biomanufacturing company that produces high-value bioactive molecules for cosmetics, pharmaceutical, food, and agriculture customers using proprietary plant stem cell culture technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEdinburgh, United Kingdom
HQ citystring
Edinburgh
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plant cell biomanufacturing, bioactive ingredients, plant natural products, sustainable cosmetics ingredients, pharmaceutical biomanufacturing
Industry3 codes
PRIMARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Plant-based Biomanufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Bioactive Ingredient Sales
TypeOne Time License
Description

Sale of sustainably manufactured plant bioactive molecules to cosmetics, pharmaceutical, food, and agricultural companies. Revenue generated through direct B2B sales of ingredients produced via the company's plant cell culture platform.

green-bioactives.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Green Bioactives operates a sustainable plant cell-based biomanufacturing platform that uses plant vascular stem cells and cell cultures, combined with natural plant biochemistry, to produce high-value bioactive molecules. The platform enables continuous, scalable production of plant-derived ingredients independent of seasonality, climate, or traditional agriculture, serving the cosmetics, pharmaceutical, food and beverage, and agricultural sectors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Green Bioactives offers a single unified product: its proprietary plant cell biomanufacturing platform. This platform leverages plant stem cell/cell culture technology combined with natural plant biochemistry to produce high-value bioactive molecules. The technology enables the company to control the complete biomanufacturing process to increase yields of target plant molecules, serving multiple industries including cosmetics, pharmaceuticals, food, and agriculture.

Product and service1 record
1Plant Cell Biomanufacturing Platform
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1University of Edinburgh
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Green Bioactives originated from University of Edinburgh research. Founder Gary Loake was a Professor of Molecular Plant Sciences at the University. The company was established through the ICURe programme and maintains connections for ongoing research collaboration.

green-bioactives.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The company opened its research lab at the Roslin Innovation Centre (RIC) in March 2020, indicating a strategic location partnership for R&D activities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Green Bioactives has received IBioIC grant funding and founder Gary Loake was a former governing Board member of IBioIC, a networking and support organisation connecting industry, academia and government.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Company worked with Edinburgh Innovations, the university's commercialization arm. Former team member Samuel Casasola-Zamora was a PhD Tech Transfer Intern at Edinburgh Innovations before joining GBL.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French plant-derived bioactive ingredient company using proprietary plant cell culture and aeroponic cultivation to produce high-value specialty molecules for cosmetics, pharma and nutraceuticals. Directly comparable as a smaller plant cell culture platform pursuing the same bioactive-molecule markets.

2Mibelle Biochemistry
TypeDirect peer
Description

Swiss pioneer of plant cell culture technology for cosmetic active ingredients (e.g., PhytoCellTec line), producing plant stem cell-derived actives for personal care brands. Closest direct peer in plant cell culture manufacturing for high-value bioactive cosmetic ingredients.

TypeDirect peer
Description

US synthetic biology company developing ingredients via fermentation for food, flavor, fragrance, cosmetics and pharma customers. Comparable as a biomanufacturing platform producing plant-equivalent bioactive molecules via cell-based processes, though Conagen relies on microbial rather than plant cell cultures.

TypeDirect peer
Description

US-listed enzyme engineering and biocatalysis company with pharmaceutical manufacturing and sustainable manufacturing lines. Comparable as a cell-based biomanufacturing platform producing high-value specialty molecules via engineered biological processes.

TypeEmerging player
Description

Carbon-to-product biomanufacturing platform using engineered microbes to produce fuels, chemicals and ingredients. Comparable as a gas/feedstock-to-bioproducts platform with similar GTM motion of selling sustainable ingredients to major CPG and industrial customers.

6Amyris
TypeBroad incumbent
Description

Synthetic biology company producing plant-derived ingredients (squalane, Reb M, etc.) for cosmetics, flavors and nutraceuticals via yeast fermentation. Comparable ingredient portfolio and customer segments, though Amyris has broader product breadth and a more difficult commercial trajectory.

TypeBroad incumbent
Description

FTSE-listed specialty ingredients supplier with major botanical actives portfolio across personal care, pharma and crop care. Comparable as a buyer/seller of natural bioactives into the same cosmetics, pharma and agriculture customers Green Bioactives targets.

TypeBroad incumbent
Description

Global flavors and fragrances leader with growing natural ingredients and bioactive molecule portfolio, including biotech-derived ingredients. Comparable as a large incumbent customer/competitor in cosmetic and nutraceutical bioactives.

TypeBroad incumbent
Description

Global chemicals giant with a dedicated Biosolutions division producing plant-derived and fermentation-derived ingredients for cosmetics, crop protection and pharma. Comparable as a broad incumbent with overlapping biomanufacturing capabilities and customer reach.

TypeBroad incumbent
Description

German specialty chemicals company with a Next Generation Solutions / biosolutions portfolio producing biotech-derived ingredients for cosmetics, pharma and agriculture. Comparable as a broad incumbent with adjacent biomanufacturing platforms and global customer relationships.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Green Bioactives

Plant-based Biomanufacturinggreen-bioactives.com

Green Bioactives is a Scottish plant cell-based biomanufacturing company that produces high-value bioactive molecules for cosmetics, pharmaceutical, food, and agriculture customers using proprietary plant stem cell culture technology.

What Green Bioactives does

Green Bioactives Ltd is a Scottish plant cell-based biomanufacturing company that develops and produces high-value bioactive molecules for the cosmetics, pharmaceutical, food, and agriculture sectors. The company's core technology is a proprietary plant cell culture platform that utilizes plant vascular stem cells and natural plant biochemistry to produce target biomolecules sustainably, independent of seasonality, climate, or agricultural supply chains. The platform combines enabling technologies, expertise, and intellectual property to control the complete production process and increase yields of target molecules, with demonstrated applications including paclitaxel production for chemotherapy and sustainable cosmetic ingredient manufacturing.

The company originated from research at the University of Edinburgh and was established through the ICURe programme funded by Innovate UK in 2018-2019. It operates from a research lab at the Roslin Innovation Centre and headquarters at Pentlands Science Park in Penicuik, Scotland. The team is led by founder/CSO Gary Loake (former Edinburgh professor) and CEO David McElroy (experienced agbio entrepreneur), with senior leadership including CBO Chris Meaney, CFO John Craig, and Head of Operations Andy Hall-Ponselé.

Green Bioactives generates revenue through direct B2B sales of sustainably manufactured bioactive ingredients to enterprise customers in target industries, using a quote-based pricing model for bulk ingredient orders. The company pursues a horizontal go-to-market strategy across four verticals and relies on partnership-driven market access and its university spin-out heritage for credibility. To date, the company has raised a £2.6M seed round led by Eos Advisory LLP (December 2022) and secured up to £1.1M in grant funding from Scottish Enterprise (April 2025) to scale its technology for the cosmetics and personal care market.

Green Bioactives firmographics

Firmographics
Name
Green Bioactives
Legal name
Green Bioactives Ltd
Website
https://green-bioactives.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Green Bioactives is a Scottish plant cell-based biomanufacturing company that produces high-value bioactive molecules for cosmetics, pharmaceutical, food, and agriculture customers using proprietary plant stem cell culture technology.
Ownership category
akta.pro rank

Green Bioactives industry classification

Industry
Product category
Plant-based Biomanufacturing
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Plant cell biomanufacturing
  • Bioactive ingredients
  • Plant natural products
  • Sustainable cosmetics ingredients
  • Pharmaceutical biomanufacturing

Where Green Bioactives is headquartered

Location

Headquarters

HQ city
Edinburgh
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Green Bioactives business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Bioactive Ingredient Sales: Sale of sustainably manufactured plant bioactive molecules to cosmetics, pharmaceutical, food, and agricultural companies. Revenue generated through direct B2B sales of ingredients produced via the company's plant cell culture platform.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Green Bioactives product offering

Product offering

Core offering

Green Bioactives operates a sustainable plant cell-based biomanufacturing platform that uses plant vascular stem cells and cell cultures, combined with natural plant biochemistry, to produce high-value bioactive molecules. The platform enables continuous, scalable production of plant-derived ingredients independent of seasonality, climate, or traditional agriculture, serving the cosmetics, pharmaceutical, food and beverage, and agricultural sectors.

Product overview

Green Bioactives offers a single unified product: its proprietary plant cell biomanufacturing platform. This platform leverages plant stem cell/cell culture technology combined with natural plant biochemistry to produce high-value bioactive molecules. The technology enables the company to control the complete biomanufacturing process to increase yields of target plant molecules, serving multiple industries including cosmetics, pharmaceuticals, food, and agriculture.

Differentiator

Problem solved

Functional benefit

Products and services

  • Plant Cell Biomanufacturing Platform

Companies that use Green Bioactives

Customer profile

Segments4 records

Ideal customer profiles4 records

Green Bioactives technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Green Bioactives partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • University of EdinburghcoreStrategic or Co-development PartnerGreen Bioactives originated from University of Edinburgh research. Founder Gary Loake was a Professor of Molecular Plant Sciences at the University. The company was established through the ICURe programme and maintains connections for ongoing research collaboration.
  • Roslin Innovation CentrecoreStrategic or Co-development PartnerThe company opened its research lab at the Roslin Innovation Centre (RIC) in March 2020, indicating a strategic location partnership for R&D activities.
  • IBioIC (Scottish Industrial Biotechnology Innovation Centre)minorStrategic or Co-development PartnerGreen Bioactives has received IBioIC grant funding and founder Gary Loake was a former governing Board member of IBioIC, a networking and support organisation connecting industry, academia and government.
  • Edinburgh InnovationsminorStrategic or Co-development PartnerCompany worked with Edinburgh Innovations, the university's commercialization arm. Former team member Samuel Casasola-Zamora was a PhD Tech Transfer Intern at Edinburgh Innovations before joining GBL.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Green Bioactives competitors and assessment

Company assessment

Direct peers

  • Plant Advanced Technologies (PAT): French plant-derived bioactive ingredient company using proprietary plant cell culture and aeroponic cultivation to produce high-value specialty molecules for cosmetics, pharma and nutraceuticals. Directly comparable as a smaller plant cell culture platform pursuing the same bioactive-molecule markets.
  • Mibelle Biochemistry: Swiss pioneer of plant cell culture technology for cosmetic active ingredients (e.g., PhytoCellTec line), producing plant stem cell-derived actives for personal care brands. Closest direct peer in plant cell culture manufacturing for high-value bioactive cosmetic ingredients.
  • Conagen: US synthetic biology company developing ingredients via fermentation for food, flavor, fragrance, cosmetics and pharma customers. Comparable as a biomanufacturing platform producing plant-equivalent bioactive molecules via cell-based processes, though Conagen relies on microbial rather than plant cell cultures.
  • Codexis: US-listed enzyme engineering and biocatalysis company with pharmaceutical manufacturing and sustainable manufacturing lines. Comparable as a cell-based biomanufacturing platform producing high-value specialty molecules via engineered biological processes.

Emerging players

  • LanzaTech: Carbon-to-product biomanufacturing platform using engineered microbes to produce fuels, chemicals and ingredients. Comparable as a gas/feedstock-to-bioproducts platform with similar GTM motion of selling sustainable ingredients to major CPG and industrial customers.

Broad incumbents

  • Amyris: Synthetic biology company producing plant-derived ingredients (squalane, Reb M, etc.) for cosmetics, flavors and nutraceuticals via yeast fermentation. Comparable ingredient portfolio and customer segments, though Amyris has broader product breadth and a more difficult commercial trajectory.
  • Croda International: FTSE-listed specialty ingredients supplier with major botanical actives portfolio across personal care, pharma and crop care. Comparable as a buyer/seller of natural bioactives into the same cosmetics, pharma and agriculture customers Green Bioactives targets.
  • Givaudan: Global flavors and fragrances leader with growing natural ingredients and bioactive molecule portfolio, including biotech-derived ingredients. Comparable as a large incumbent customer/competitor in cosmetic and nutraceutical bioactives.
  • BASF: Global chemicals giant with a dedicated Biosolutions division producing plant-derived and fermentation-derived ingredients for cosmetics, crop protection and pharma. Comparable as a broad incumbent with overlapping biomanufacturing capabilities and customer reach.
  • Evonik: German specialty chemicals company with a Next Generation Solutions / biosolutions portfolio producing biotech-derived ingredients for cosmetics, pharma and agriculture. Comparable as a broad incumbent with adjacent biomanufacturing platforms and global customer relationships.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Green Bioactives social profiles

Digital presence

Green Bioactives financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Green Bioactives leadership team

Management profile

Number of profiles

Profiles8 records

Green Bioactives funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Green Bioactives M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Green Bioactives

What does Green Bioactives do?

Green Bioactives operates a sustainable plant cell-based biomanufacturing platform that uses plant vascular stem cells and cell cultures, combined with natural plant biochemistry, to produce high-value bioactive molecules. The platform enables continuous, scalable production of plant-derived ingredients independent of seasonality, climate, or traditional agriculture, serving the cosmetics, pharmaceutical, food and beverage, and agricultural sectors.

Is Green Bioactives a public or private company?

Green Bioactives is a private company. It is classified as venture growth investor backed and is currently operating.

When was Green Bioactives founded?

Green Bioactives was founded in 2019. It employs 11 to 50 people.

Where is Green Bioactives based?

Green Bioactives is headquartered in Edinburgh, United Kingdom, in the Europe region.

How does Green Bioactives make money?

One revenue line is on record: bioactive Ingredient Sales.

Who are Green Bioactives's main competitors?

Direct peers on record are Plant Advanced Technologies (PAT), Mibelle Biochemistry, Conagen and Codexis. LanzaTech is listed as an emerging player. Broad incumbents are Amyris, Croda International, Givaudan, BASF and Evonik.

Does Green Bioactives have an API?

No public API is recorded for Green Bioactives.

What industry is Green Bioactives in?

Green Bioactives's product category is Plant-based Biomanufacturing. Its primary akta.pro industry code is EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives, with a secondary code of EUAAAIAJ, Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Global Cosmetic IndustryTop Ten Biotech Innovator Secures Up to £1.1 Million Investment From Scottish EnterpriseGreen Bioactives secured up to £1.1 million from Scottish Enterprise to advance sustainable plant-based product innovation. The funding will support an 18-month R&D initiative to scale production of plant-derived ingredients for cosmetic and personal care industries.businessInsiderScottish biotech start-up secures £1.1 million grantGreen Bioactives secured a £1.09m grant from Scottish Enterprise for an 18-month R&D initiative on plant cell culture-derived natural products. The funding will support scale-up and supply to cosmetic and personal care industries, aiming to provide sustainable alternatives to conventionally-sourced bioactives.AgFunderNewsPlant cell culture deep dive: As cracks emerge in botanical supply chains, ‘It’s a huge space to watch’A growing number of startups, including Chi Botanic, Green Bioactives, and Ayana Bio, are leveraging plant cell culture technology to produce high-value botanical compounds in bioreactors, aiming to secure supply chains against climate change and agricultural volatility. These companies argue that the method offers superior sustainability, consistency, and yield compared to traditional farming or microbial fermentation, particularly for complex ingredients like vanilla and aloe. The sector is attracting venture capital investment as investors view it as a significant opportunity within the food and nutraceutical industries.PR NewswireGreen Bioactives completes £2.6m seed financing to advance its sustainable plant products biomanufacturing platformGreen Bioactives completed a £2.6 million seed financing round led by Eos Advisory LLP, with participation from Regenerate Ventures, Milltrust International Group, and Scottish Enterprise. The funds will support partnerships, IP, and team expansion to scale its plant cell culture biomanufacturing platform. The company aims to become the world's leading supplier of sustainable plant-derived products.FinSMEsGreen Bioactives Closes £2.6M in Seed FinancingGreen Bioactives, based in Edinburgh, UK, has successfully raised £2.6M in Seed financing led by Eos Advisory LLP, with contributions from Regenerate Ventures’ Agtech Fund, Milltrust International Group, and Scottish Enterprise. The funding will be used to expand the company's management, production, and research team capabilities, as well as to scale up its biomanufacturing efforts. Green Bioactives focuses on sustainable biomanufacturing from plant vascular stem cells, targeting applications across cosmetics, pharmaceuticals, food, and agriculture.